Search Results 161-170 of 316 for ⚠우리계열 【원벳원보증.com / 가입코드 9192】 우리계열 ⚠

  1. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Participation eligibility.

  2. Study to Determine Safety and Effectiveness of Ascorbic Acid, Corticosteroids, and Thiamine in Treating Sepsis and Septic Shock - Mayo Clinic

    The purpose of this study is to determine whether the combination of Ascorbic Acid (Vitamin C), Thiamine (Vitamin B1), and Corticosteroids improves the ...

  3. Efficacy and Safety of Seralutinib in Adult Subjects With PAH - Mayo Clinic

    The primary objective of the study is to determine the effect of seralutinib on improving exercise capacity in subjects with WHO Group 1 PAH who are FC II or ...

  4. Px Code,Supply #,Description,Unit Price 278000024,48589,CATH ABL THRMCL ST FJ,"5,504.00" 278000025,55648,CATH ABL CLS NON-NAV 6FX4,"1,312.00" 278000026 ...

  5. Cardiovascular Medicine - Clinical trials - Mayo Clinic

    Rochester, Minn. The purpose of this study is to elucidate the genetic basis of aBiMVP in hopes of determining novel mechanisms that underlie aBiMVP ...

  6. A Study to Evaluate the Safety, Effectiveness and Tolerability of APG-2575 in Patients with Waldenström Macroglobulinemia - Mayo Clinic

    About this study. The purpose of this study is to assess the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose ...

  7. https://www.mayoclinic.org/~/media/0439A7376021433E8FB3180F95C8FF95

  8. A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease - Mayo Clinic

    The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered ...

  9. Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol - Mayo Clinic

    This is a Phase III, placebo-controlled, double-blind, randomized study in participants with ASCVD and elevated LDL-C despite maximum tolerated dose of LDL-C ...

  10. Publications - Dong Chen, M.D., Ph.D. - Mayo Clinic

    He R, Chen D. Myelodysplastic neoplasm with biallelic TP53 inactivation in a patient with plasma cell myeloma after cytotoxic therapy. Blood.